Stock Analysis on Net
Stock Analysis on Net

Illumina Inc. (NASDAQ:ILMN)

This company has been moved to the archive! The financial data has not been updated since November 5, 2021.

Debt to Equity 
since 2005

Microsoft Excel

Calculation

Illumina Inc., debt to equity, long-term trends, calculation

Microsoft Excel
Debt to equity = Long-term debt1 ÷ Illumina stockholders’ equity1
Dec 31, 2020 0.25 = 1,184 ÷ 4,694
Dec 29, 2019 0.25 = 1,141 ÷ 4,613
Dec 30, 2018 0.53 = 1,997 ÷ 3,758
Dec 31, 2017 0.49 = 1,336 ÷ 2,749
Jan 1, 2017 0.58 = 1,272 ÷ 2,197
Jan 3, 2016 0.60 = 1,100 ÷ 1,849
Dec 28, 2014 0.88 = 1,291 ÷ 1,463
Dec 29, 2013 0.57 = 869 ÷ 1,533
Dec 30, 2012 0.64 = 842 ÷ 1,319
Jan 1, 2012 0.75 = 807 ÷ 1,075
Jan 2, 2011 0.26 = 312 ÷ 1,198
Jan 3, 2010 0.34 = 290 ÷ 864
Dec 28, 2008 0.47 = 400 ÷ 849
Dec 30, 2007 0.97 = 400 ÷ 412
Dec 31, 2006 0.00 = — ÷ 247
Jan 1, 2006 0.00 = — ÷ 72

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).

1 US$ in millions

Comparison to Competitors

Illumina Inc., debt to equity, long-term trends, comparison to competitors

Microsoft Excel
Illumina Inc. AbbVie Inc. Amgen Inc. Bristol-Myers Squibb Co. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc.
Dec 31, 2020 0.25 6.58 3.51 1.34 0.53 2.94 1.73 0.56 1.26 0.63 0.24 0.63
Dec 29, 2019 0.25 — 3.09 0.91 0.72 5.88 1.09 0.47 1.02 0.83 0.06 0.60
Dec 30, 2018 0.53 — 2.71 0.52 0.35 1.30 1.28 0.51 0.94 0.66 0.08 0.69
Dec 31, 2017 0.49 7.33 1.40 0.68 0.40 1.18 1.64 0.57 0.71 0.60 0.11 0.83
Jan 1, 2017 0.58 7.95 1.16 0.41 0.53 0.74 1.39 0.39 0.62 0.71 0.11 0.77
Jan 3, 2016 0.60 8.03 1.12 0.47 0.54 0.55 1.20 0.28 0.59 0.60 0.10 0.59
Dec 28, 2014 0.88 8.62 1.19 0.53 0.15 0.52 0.80 0.27 0.44 0.51 0.18 0.71
Dec 29, 2013 0.57 3.28 1.45 0.55 0.16 0.30 0.58 0.25 0.50 0.48 0.26 0.62
Dec 30, 2012 0.64 4.66 1.39 0.54 0.28 0.37 0.88 0.25 0.39 0.46 0.37 0.46
Jan 1, 2012 0.75 — 1.13 0.34 0.31 0.52 1.13 0.34 0.32 0.47 0.90 0.47
Jan 2, 2011 0.26 — 0.56 0.35 0.21 0.56 0.59 0.30 0.33 0.50 0.31 0.14
Jan 3, 2010 0.34 — 0.47 0.43 0.25 0.70 0.18 0.29 0.30 0.54 0.27 0.14
Dec 28, 2008 0.47 — 0.50 0.55 0.27 1.55 0.31 0.28 0.33 0.30 0.00 0.14
Dec 30, 2007 0.97 — 0.63 0.59 0.41 0.37 0.38 0.22 0.32 0.20 0.43 0.15
Dec 31, 2006 0.00 — 0.48 0.74 0.37 0.34 0.77 0.17 0.39 0.11 0.92 0.19
Jan 1, 2006 0.00 — 0.19 0.77 0.21 0.60 0.10 0.07 0.45 0.27 1.75 0.21

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Illumina Inc., debt to equity, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Illumina Inc. Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2020 0.25 1.15
Dec 29, 2019 0.25 1.11
Dec 30, 2018 0.53 0.94
Dec 31, 2017 0.49 0.88
Jan 1, 2017 0.58 0.79
Jan 3, 2016 0.60 0.68
Dec 28, 2014 0.88 0.55
Dec 29, 2013 0.57 0.52
Dec 30, 2012 0.64 0.51
Jan 1, 2012 0.75 0.46
Jan 2, 2011 0.26 0.39
Jan 3, 2010 0.34 0.39
Dec 28, 2008 0.47 0.37
Dec 30, 2007 0.97 0.30
Dec 31, 2006 0.00 0.25
Jan 1, 2006 0.00 0.29

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).

Comparison to Industry (Health Care)

Illumina Inc., debt to equity, long-term trends, comparison to industry (health care)

Microsoft Excel
Illumina Inc. Health Care
Dec 31, 2020 0.25 0.90
Dec 29, 2019 0.25 0.91
Dec 30, 2018 0.53 0.87
Dec 31, 2017 0.49 0.79
Jan 1, 2017 0.58 0.75
Jan 3, 2016 0.60 0.68
Dec 28, 2014 0.88 0.52
Dec 29, 2013 0.57 0.49
Dec 30, 2012 0.64 0.51
Jan 1, 2012 0.75 0.45
Jan 2, 2011 0.26 0.41
Jan 3, 2010 0.34 0.41
Dec 28, 2008 0.47 0.41
Dec 30, 2007 0.97 0.36
Dec 31, 2006 0.00 0.33
Jan 1, 2006 0.00 0.30

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).